BRIEF-Amicus expands pipeline with new program for CDKl5 deficiency
July 06, 2016 at 16:17 PM EDT
* Acquisition of Miamed does not impact previous full-year 2016 net cash spend guidance of $135 million to $155 million
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.